Data · dataset · 2026
Identification and bioactivity assessment of a host-defence peptide, QUB-2654, from the skin secretion of the frog, Agalychnis callidryas
Listed in ZivaHub and Deakin Research Online and DMU Figshare and UCL Research Data Repository — shown once because both records carry DOI 10.17034/32633370.v1
Amphibian skin secretions contain a wide array of antimicrobial peptides with biological activities, providing an effective first-line of defence against microbial invasion.
Description
This thesis aims to characterise an antimicrobial peptide from the skin secretion of the Central American red-eyed tree frog, Agalychnis callidryas and to study its biological properties. Firstly, the cDNA sequence encoding an antimicrobial peptide (QUB-2654) precursor, was identified from the frog skin secretions extracted mRNAs through rapid-amplification of cDNA ends (RACE) PCR, molecular cloning and Sanger sequencing strategies.
Next, the peptide was synthesised using a solid-phase peptide synthesiser, purified by reversed-phase high-performance liquid chromatography and corroborated by MALDI-TOF mass spectrometry. The purified peptide was tested for its antimicrobial activity, anti-lung cancer cell activity and haemolytic effect, by a series of bioassays. This study showed that QUB-2654 had significant bacteriostatic and bactericidal activities against a Gram-positive bacterium, Staphylococcus aureus (ATCC-CRM 6538) (MIC=3.125 µM, MBC=6.25 µM) and a Gram-negative bacterium, Escherichia coli (ATCC-CRM 8739) (MIC/MBC=6.25 µM), but the MIC value against Candida albicans (ATCC-CRM 10231) was not detected even at the highest peptide concentration.
Read the rest (1 more)
In addition, QUB-2654 statistically demonstrated anti-proliferative and killing effects against NCI-H838 human lung cancer cells at and above a concentration of 10 µM. The peptide concentration required to achieve half-maximal inhibition (IC50) of the NCI-H838 cells was 11.32 µM. This peptide was not haemolytic (<5% haemolysis) at the MBC values for S.aureus and E.coli, and at the IC50 value for NCI-H838 cells. These results suggest that peptide QUB-2654 has the potential to be developed as an antibacterial and anticancer drug.<br><br><i>Thesis is embargoed until 31 December 2027.</i>
Links
Where it is published
- DOI doi.org/10.17034/32633370.v1 ↗
DOI / persistent id · from zivahub uct ac za
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from zivahub uct ac za
Topics
- From keywords
- Earth & Environmental Science · Earth & Environmental Science · Earth & Environmental Science · Earth & Environmental Science · Medicine & Health · Medicine & Health · Medicine & Health · Medicine & Health
- Inferred from text
- Cancer 75% · Mass spectrometry 75% · Sequencing 75%
Provenance · 4 source records, 16 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| ZivaHub | oai:figshare.com:article/32633370 | 12 d ago | JSON v1 |
| Deakin Research Online | oai:figshare.com:article/32633370 | 12 d ago | JSON v1 |
| DMU Figshare | oai:figshare.com:article/32633370 | 12 d ago | JSON v1 |
| UCL Research Data Repository | oai:figshare.com:article/32633370 | 12 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[disease].local:disease:cancer | enrichment · zivahub uct ac za | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[field].local:field:earth-environmental | mapping · dro deakin edu au | connector:dro_deakin_edu_au@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · figshare dmu ac uk | connector:figshare_dmu_ac_uk@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · dro deakin edu au | connector:dro_deakin_edu_au@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · figshare dmu ac uk | connector:figshare_dmu_ac_uk@1.0.0 | |
| concepts[field].local:field:medicine-health | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[modality].local:modality:mass-spectrometry | enrichment · zivahub uct ac za | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[modality].local:modality:sequencing | enrichment · zivahub uct ac za | keyword-concept-rules@1.0.0 | title+description (75%) |
| description | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/description |
| license_text | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| publication_date | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| title | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/title |